As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
Accelerating MMC adoption in Australia with Martin Fenn from PT Blink in conversation with Adam Jordan and Simon McCarthy from Bryden Wood
Built Environment Matters
29 minutes
3 years ago
Accelerating MMC adoption in Australia with Martin Fenn from PT Blink in conversation with Adam Jordan and Simon McCarthy from Bryden Wood
What is the current state of MMC adoption in Australia and what can be done to accelerate it? How can we best apply the lessons from overseas, particularly looking at the experience in the UK? Adam Jordan, Asia-Pacific Lead at Bryden Wood, talks to Martin Fenn, Director of Integration at PT Blink and MMC Lead for the CIOB Oceania. They are joined by Simon McCarthy, Principal Structural Engineer from Bryden Wood.We'll be discussing some of the most important topics in the construction industry...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
